Tyson Foods Other Income (Expense) increased by 56.6% to -$76.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.6%, from -$70.00M to -$76.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows relatively stable performance with a -1.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$96.00M | -$74.00M | -$45.00M | -$69.00M | -$47.00M | -$100.00M | -$33.00M | -$81.00M | -$76.00M | -$93.00M | -$70.00M | -$109.00M | -$88.00M | -$50.00M | -$102.00M | -$70.00M | -$67.00M | -$90.00M | -$175.00M | -$76.00M |
| QoQ Change | — | +22.9% | +39.2% | -53.3% | +31.9% | -112.8% | +67.0% | -145.5% | +6.2% | -22.4% | +24.7% | -55.7% | +19.3% | +43.2% | -104.0% | +31.4% | +4.3% | -34.3% | -94.4% | +56.6% |
| YoY Change | — | — | — | — | +51.0% | -35.1% | +26.7% | -17.4% | -61.7% | +7.0% | -112.1% | -34.6% | -15.8% | +46.2% | -45.7% | +35.8% | +23.9% | -80.0% | -71.6% | -8.6% |